Dibaglim PM 1mg/500mg/15mg Tablet
Marketer
Kasdap Healthcare Pvt Ltd
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Dibaglim PM 1mg/500mg/15mg Tablet
Glimepiride-metformin-pioglitazone 1mg/500mg/15mg tablets manage blood glucose in adults with type 2 diabetes. Used alongside diet and exercise, this combined medication enhances insulin effectiveness, reducing blood sugar. Follow your doctor's prescribed dosage and regimen; take with food to prevent digestive issues. If a dose is missed, take it promptly unless the next dose is imminent; never double the dose. Overdosing can cause dangerously low blood sugar (hypoglycemia). Hypoglycemia is possible when combined with other diabetes medications, alcohol, or missed meals; monitor blood sugar regularly. Common side effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Inform your physician of any kidney, liver, or heart conditions before use; pregnant or breastfeeding individuals should also seek medical advice. Kidney function will be assessed before treatment commences. Limit alcohol consumption to minimize side effect risk.
Primary Ingredients of Dibaglim PM 1mg/500mg/15mg Tablet
No text provided. Please provide the text you wish to be rewritten.
Uses of Dibaglim PM 1mg/500mg/15mg Tablet
Managing Type 2 Diabetes
Major Benefits of Dibaglim PM 1mg/500mg/15mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Dibaglim PM 1mg/500mg/15mg tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with a meal.
Common Side effects of Dibaglim PM 1mg/500mg/15mg Tablet:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Dibaglim PM 1mg/500mg/15mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Dibaglim PM 1mg/500mg/15mg Tablet should be administered with a meal.
How Dibaglim PM 1mg/500mg/15mg Tablet works:
Dibaglim PM 1mg/500mg/15mg tablets combine glimepiride, metformin, and pioglitazone—three antidiabetic agents with distinct actions—to optimize blood glucose management when monotherapy or dual therapy proves inadequate. Glimepiride, a sulfonylurea, stimulates pancreatic insulin release, thus reducing blood glucose levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin sensitivity. Pioglitazone, a thiazolidinedione, further improves insulin responsiveness.
SAFETY ADVICE
AlcoholUNSAFE
Alcohol consumption alongside Dibaglim PM 1mg/500mg/15mg tablets is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Dibaglim PM 1mg/500mg/15mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice before using this medication.
Breast feedingCONSULT YOUR DOCTOR
Use of Dibaglim PM 1mg/500mg/15mg tablets while breastfeeding is likely inadvisable. Preliminary data from human studies indicate potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving may be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Patients with kidney impairment should use Dibaglim PM 1mg/500mg/15mg tablets cautiously, potentially requiring dosage modification. Consult a physician for guidance. In cases of severe kidney disease, this medication is contraindicated. Routine kidney function monitoring is recommended during treatment.
LiverCAUTION
Patients with liver impairment should exercise caution when using Dibaglim PM 1mg/500mg/15mg tablets, as dose modification may be necessary. Consult your physician for guidance. Dibaglim PM 1mg/500mg/15mg tablets are contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Dibaglim PM 1mg/500mg/15mg Tablet :
Should you forget a dose of Dibaglim PM 1mg/500mg/15mg Tablet, take it immediately if you remember. However, near the time for your next dose, omit the missed dose and resume your usual dosing schedule. Never take more than the prescribed amount.
Facts to Know About Dibaglim PM 1mg/500mg/15mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently